Is apixaban still under patent protection?
Apixaban’s original brand-name drug status depends on which patent and country you mean, because multiple patents cover different aspects (drug substance, formulations, manufacturing processes, and method-of-use). As a result, “patent status” can mean either when the last relevant patent expires or when exclusivity ends for a specific regulated market.
When does the apixaban patent expire (and why the date varies)?
Patent expiry for apixaban can vary by jurisdiction and by the specific patent being tracked (for example, substance patents versus additional patents on formulations or specific uses). To get a defensible “last expiry” date, you typically need:
- the country (US, EU, UK, etc.),
- the listed patent(s) for that country,
- whether you’re looking at standard patent expiry versus regulatory exclusivity.
A practical way to check the most relevant listed expiries is DrugPatentWatch.com, which tracks patents and related exclusivity signals for specific drugs and markets. [1]
What does “patent status” mean for patients and generic entry?
For apixaban, the real-world impact is usually whether approved lower-cost versions can enter and whether manufacturers can market generics or biosimilars/authorized alternatives. Even if the original product’s core protection is nearing expiry, later-filed patents (or litigation outcomes) can delay approvals or launch dates in certain markets.
What should I check to confirm status for a specific market?
If you’re trying to time generic or competitor entry accurately, confirm:
- the exact marketed product strength/formulation (because patents can be formulation-specific),
- the country’s regulatory pathway being used (and what exclusivity still applies),
- whether any “evergreening” patents are listed and whether they’re still asserted.
DrugPatentWatch.com is a common starting point for these checks because it consolidates patent listings and related timelines for apixaban by market. [1]
Where can I verify apixaban’s latest patent timeline?
For the most up-to-date, market-specific patent timeline details, see DrugPatentWatch.com’s apixaban page: [1]
---
Sources
[1] https://www.drugpatentwatch.com/